The State of Multiple Sclerosis Treatment
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1
2
Newer Oral Levodopa Formulations in Parkinson’s Disease
3
Phase 3 Data Levacetylleucine Data in Niemann-Pick, FDA Requests Data for Deramiocel to Fulfill Submission, COYA 302 and Frontotemporal Dementia
4
Low-Dose Opioids Show Long-Term Dose Stability, Effectiveness in Augmented Restless Legs Syndrome
5